Before Lourie, Dyk, and Hughes. Appeals from the United States Patent and Trademark Office. Summary: The Patent Trial and Appeal Board ...

today issued the following statement in response to the Patent Trial and Appeal Board’s (PTAB) final written decision in PGR2023-00043 regarding U.S. Patent No. 11,572,334 (the “’334 patent”). Atossa ...

The Federal Circuit affirmed on Thursday a ruling invalidating a semiconductor patent that’s part of a long-running ...

Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today ...

The US Patent and Trademark Office told a group of specialized patent judges on Tuesday afternoon they could be expected to ...

This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Further to reports that PTAB judges will soon be required to return to the office, the lingering question for many is what effect the order—as well as the current, indefinite hiring freeze—will have ...

Atossa Therapeutics, Inc. expressed disappointment over the Patent Trial and Appeal Board's ruling deeming all challenged claims of U.S. Patent No. 11,572,334 unpatentable. While Atossa will not ...

Kristina Caggiano Kelly, David H. Holman and Lestin L. Kenton Jr. of Sterne, Kessler, Goldstein & Fox PLLC discuss a Federal ...

This week, hearings set before the Federal Court of Appeal and the Federal Court included matters relating to a Canadian Radio-television and Telecommunications Commission (CRTC) broadcasting policy, ...